"Developing New Drugs…"

Welcome to Connecting ALS. This week Jeremy is joined by guest co-host Dr. Kuldip Dave and Dr. Daniel Elbaum to dig into the Lawrence and Isabel Barnett Drug Development Program.

Show Notes

This week Jeremy is joined by guest co-host Dr. Kuldip Dave, vice president of research at The ALS Association, and interviews Dr. Daniel Elbaum, chief scientific officer at QurAlis, to dig into the Lawrence and Isabel Barnett Drug Development Program.

Learn more about the Lawrence and Isabel Barnett Drug Development Program at https://www.als.org/research/research-we-fund/partnerships-initiatives/lawrence-and-isabel-barnett-drug-development

See how the Barnett family continues to lead in the fight against ALS at https://www.als.org/blog/meet-sophia-harding-carrying-her-great-grandfathers-legacy-fight-against-als

Stay up-to-date with the latest ALS research news by signing up for The ALS Association’s monthly e-newsletter, Research Matters https://www.als.org/research-matters-sign-up

This episode is brought to you by The ALS Association in partnership with CitizenRacecar.

What is Connecting ALS?

Connecting ALS is a weekly podcast produced by The ALS Association in partnership with CitizenRacecar. We aim to discuss research and technology developments, highlight advocacy efforts, and share the personal stories woven through the community.